DZ3014A1 - Médicaments pour le traitement de l'hypertension. - Google Patents

Médicaments pour le traitement de l'hypertension.

Info

Publication number
DZ3014A1
DZ3014A1 DZ000029A DZ000029A DZ3014A1 DZ 3014 A1 DZ3014 A1 DZ 3014A1 DZ 000029 A DZ000029 A DZ 000029A DZ 000029 A DZ000029 A DZ 000029A DZ 3014 A1 DZ3014 A1 DZ 3014A1
Authority
DZ
Algeria
Prior art keywords
hypertension
medicines
treatment
Prior art date
Application number
DZ000029A
Other languages
English (en)
French (fr)
Inventor
Martin R Wilkins
Dirk Thormahlen
Harald Waldeck
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DZ3014A1 publication Critical patent/DZ3014A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ000029A 1999-02-16 2000-02-13 Médicaments pour le traitement de l'hypertension. DZ3014A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906310A DE19906310A1 (de) 1999-02-16 1999-02-16 Arzneimittel zur Behandlung von Bluthochdruck

Publications (1)

Publication Number Publication Date
DZ3014A1 true DZ3014A1 (fr) 2004-03-27

Family

ID=7897580

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000029A DZ3014A1 (fr) 1999-02-16 2000-02-13 Médicaments pour le traitement de l'hypertension.

Country Status (28)

Country Link
US (1) US6482820B2 (sv)
EP (1) EP1154777B1 (sv)
JP (1) JP2002537258A (sv)
KR (2) KR100797665B1 (sv)
CN (1) CN1198619C (sv)
AR (1) AR036864A1 (sv)
AT (1) ATE295174T1 (sv)
AU (1) AU773240C (sv)
BR (1) BR0008260A (sv)
CA (1) CA2362273C (sv)
CZ (1) CZ301499B6 (sv)
DE (2) DE19906310A1 (sv)
DZ (1) DZ3014A1 (sv)
ES (1) ES2238268T3 (sv)
HK (1) HK1042247B (sv)
HU (1) HUP0105491A3 (sv)
IL (1) IL144622A (sv)
NO (1) NO329588B1 (sv)
NZ (1) NZ514058A (sv)
PL (1) PL195283B1 (sv)
PT (1) PT1154777E (sv)
RU (1) RU2270679C2 (sv)
SK (1) SK287254B6 (sv)
TR (1) TR200102386T2 (sv)
TW (1) TWI221770B (sv)
UA (1) UA63032C2 (sv)
WO (1) WO2000048601A1 (sv)
ZA (1) ZA200105828B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
EP1234025B1 (en) * 1999-11-19 2008-08-27 Solvay Pharmaceuticals B.V. Human enzymes of the metalloprotease family
CA2357833C (en) * 2000-10-04 2005-11-15 Warner-Lambert Company Treatment of pulmonary hypertension using vasopressin antagonist
RU2003136077A (ru) * 2001-05-18 2005-08-10 Зольвай Фармасьютиклз Гмбх (De) Применение соединений, обладающих совместной ингибирующей активностью в отношении nep (нейтральная эндопептидаза) и мр (металлопротеаза), для приготовления лекарственных средств
PT1448567E (pt) * 2001-09-10 2010-03-12 Tibotec Pharm Ltd Método de preparação de hexa-hidro-furo[2,3-b]furan-3-ol
RU2303041C2 (ru) 2002-01-16 2007-07-20 Солвей Фармасьютикалс Б.В. Твердые соли бензазепиновых соединений и их применение при получении фармацевтических соединений
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
TWI344366B (en) 2003-11-18 2011-07-01 Solvay Pharm Gmbh Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
MX2007006279A (es) 2004-12-15 2007-06-14 Solvay Pharm Gmbh Composiciones farmaceuticas que comprenden inhibidores de nep, inhibidores del sistema de produccion de endotelina endogena, e inhibidores de hmg coa-reductasa.
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent
KR20100135729A (ko) * 2008-01-31 2010-12-27 반더빌트유니버시티 폐의 용태에 따른 치료 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
DE19510566A1 (de) 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel

Also Published As

Publication number Publication date
TR200102386T2 (tr) 2002-01-21
TWI221770B (en) 2004-10-11
NZ514058A (en) 2001-09-28
BR0008260A (pt) 2001-11-06
HK1042247A1 (en) 2002-08-09
WO2000048601A1 (de) 2000-08-24
DE19906310A1 (de) 2000-08-17
SK287254B6 (sk) 2010-04-07
CA2362273C (en) 2010-05-25
HK1042247B (zh) 2005-09-23
CZ301499B6 (cs) 2010-03-24
HUP0105491A2 (en) 2002-06-29
ZA200105828B (en) 2002-07-15
CZ20012672A3 (cs) 2002-02-13
EP1154777B1 (de) 2005-05-11
SK10822001A3 (sk) 2002-03-05
UA63032C2 (en) 2004-01-15
CN1339966A (zh) 2002-03-13
PL195283B1 (pl) 2007-08-31
KR100797665B1 (ko) 2008-01-23
RU2270679C2 (ru) 2006-02-27
JP2002537258A (ja) 2002-11-05
PL350167A1 (en) 2002-11-18
AU773240C (en) 2004-11-18
US6482820B2 (en) 2002-11-19
NO329588B1 (no) 2010-11-15
KR20070027719A (ko) 2007-03-09
US20020052361A1 (en) 2002-05-02
DE50010284D1 (de) 2005-06-16
ES2238268T3 (es) 2005-09-01
PT1154777E (pt) 2005-07-29
AU2547600A (en) 2000-09-04
KR20010101922A (ko) 2001-11-15
NO20013958L (no) 2001-10-15
HUP0105491A3 (en) 2002-08-28
AR036864A1 (es) 2004-10-13
CN1198619C (zh) 2005-04-27
NO20013958D0 (no) 2001-08-15
CA2362273A1 (en) 2000-08-24
IL144622A (en) 2006-08-20
EP1154777A1 (de) 2001-11-21
AU773240B2 (en) 2004-05-20
ATE295174T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
MA26822A1 (fr) Composes pour le traitement d'une ischemie.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
MA25823A1 (fr) Compositions pour le traitement de l'eau.
DE60044625D1 (de) Système d'assistance de conduire pour vehicules
MA26914A1 (fr) Derives bicycliques substitues pour le traitement d'une croissance cellulaire anormale
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
FR2740231B1 (fr) Ebauche pour oculaire non-correcteur
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
MA25234A1 (fr) Vibromasseur pour le soulagement des maux et de la douleur.
MA26950A1 (fr) Nouveaux retinoides pour le traitement de l'emphyseme
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
MA26117A1 (fr) Nouveau compose pour le traitement de l'impuissance
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
DZ1903A1 (fr) Oligonucléotides pour inhiber le role ders isoprényl protéine transférases.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.